Galectin Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GALT and other ETFs, options, and stocks.

About GALT

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. 

CEO
Joel Lewis
CEOJoel Lewis
Employees
9
Employees9
Headquarters
Norcross, Georgia
HeadquartersNorcross, Georgia
Founded
2000
Founded2000
Employees
9
Employees9

GALT Key Statistics

Market cap
297.67M
Market cap297.67M
Price-Earnings ratio
-11.00
Price-Earnings ratio-11.00
Dividend yield
Dividend yield
Average volume
1.92M
Average volume1.92M
High today
$4.78
High today$4.78
Low today
$4.36
Low today$4.36
Open price
$4.38
Open price$4.38
Volume
721.17K
Volume721.17K
52 Week high
$7.13
52 Week high$7.13
52 Week low
$2.03
52 Week low$2.03

Stock Snapshot

With a market cap of 297.67M, Galectin Therapeutics(GALT) trades at $4.51. The stock has a price-to-earnings ratio of -11.00.

As of 2026-07-04, Galectin Therapeutics(GALT) stock has fluctuated between $4.36 and $4.78. The current price stands at $4.51, placing the stock +3.4% above today's low and -5.5% off the high.

The Galectin Therapeutics(GALT)'s current trading volume is 721.17K, compared to an average daily volume of 1.92M.

In the last year, Galectin Therapeutics(GALT) shares hit a 52-week high of $7.13 and a 52-week low of $2.03.

In the last year, Galectin Therapeutics(GALT) shares hit a 52-week high of $7.13 and a 52-week low of $2.03.

GALT News

Investing.com 4d
Galectin Therapeutics CMO Jamil Khurram disposes of $262,083 in stock - Investing.com

...

Galectin Therapeutics CMO Jamil Khurram disposes of $262,083 in stock - Investing.com

People also own

Based on the portfolios of people who own GALT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.